REGENXBIO (NASDAQ: RGNX): FDA Backs NAVSUNLI Accelerated Approval, No New Studies Required for Hunter Syndrome Gene Therapy

Key Highlights

Nitish Kishor | 22 June 2026

Achieve Life Sciences (NASDAQ: ACHV) Clears FDA Safety Hurdle, Cytisinicline Approval on Track for 2027

Key Highlights

Nitish Kishor | 22 June 2026

Align Technology (NASDAQ: ALGN) Announces Chairman Transition as Larkin Retires, Conroy Takes Helm

This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.

Nitish Kishor | 22 June 2026

AbbVie (NYSE: ABBV) Gains FDA Clearance for Skinvive, Reinforces Oncology Leadership with Long-Term CLL Data

Key Highlights

Nitish Kishor | 22 June 2026

Codexis (NASDAQ: CDXS) Shareholders Approve Board Slate, Auditor and Executive Pay Plan

Shareholder Vote Concludes

Nitish Kishor | 22 June 2026

Enliven Therapeutics (NASDAQ: ELVN) Surges as Cancer Drug Pipeline Advances; Risks Remain in Focus

Early Pipeline Momentum

Nitish Kishor | 22 June 2026

Nuvectis Pharma (NASDAQ: NVCT) Expands Pipeline With Strategic Licensing Push Into Oncology and Complement Diseases

Pipeline Expansion Announced

Nitish Kishor | 22 June 2026

Summit Therapeutics (NASDAQ: SMMT) Faces Binary Catalysts as Volatility Draws Investor Attention

High-Stakes Biotech Play

Nitish Kishor | 22 June 2026

Merck (NYSE: MRK) Boosts Oncology Revenue as FDA Greenlights Keytruda Combination for Kidney Cancer

Q1 Oncology Performance

Nitish Kishor | 22 June 2026

Insmed (NASDAQ: INSM) Advances Phase 3 TPIP Program as BRINSUPRI Sales Jump 44% in Q1 2026

Pipeline Progress Accelerates

Nitish Kishor | 22 June 2026

Healthcare

REGENXBIO (NASDAQ: RGNX): FDA Backs NAVSUNLI Accelerated Approval, No New Studies Required for Hunter Syndrome Gene Therapy

Achieve Life Sciences (NASDAQ: ACHV) Clears FDA Safety Hurdle, Cytisinicline Approval on Track for 2027

Align Technology (NASDAQ: ALGN) Announces Chairman Transition as Larkin Retires, Conroy Takes Helm

AbbVie (NYSE: ABBV) Gains FDA Clearance for Skinvive, Reinforces Oncology Leadership with Long-Term CLL Data

Codexis (NASDAQ: CDXS) Shareholders Approve Board Slate, Auditor and Executive Pay Plan

Enliven Therapeutics (NASDAQ: ELVN) Surges as Cancer Drug Pipeline Advances; Risks Remain in Focus

Nuvectis Pharma (NASDAQ: NVCT) Expands Pipeline With Strategic Licensing Push Into Oncology and Complement Diseases

Summit Therapeutics (NASDAQ: SMMT) Faces Binary Catalysts as Volatility Draws Investor Attention

Merck (NYSE: MRK) Boosts Oncology Revenue as FDA Greenlights Keytruda Combination for Kidney Cancer

Insmed (NASDAQ: INSM) Advances Phase 3 TPIP Program as BRINSUPRI Sales Jump 44% in Q1 2026

Latest News

US Allows Iran to Sell Oil in Dollars for First Time in Decades After Peace Talks Progress

Fed Hawkishness Under Warsh: What Three Rate Hikes in 2026 Would Mean for Equity Valuations

Greenspan Playbook Set for Replay Under Warsh as Fed Philosophy Shifts to Inflation Discipline

Alan Greenspan, Former Federal Reserve Chairman Who Shaped US Monetary Policy, Dies at 100

Iran and US Reach Accord on Path to Comprehensive Agreement, Pledge to Halt Lebanon Hostilities

Keir Starmer Resigns as UK Prime Minister, Triggering Leadership Contest Amid Political Turmoil